Trial Search Results

Comparison of PET/CT vs. PET/MRI

This clinical trial studies how well positron emission tomography (PET)/computed tomography (CT) works compared to PET/magnetic resonance imaging (MRI) in evaluating patients with cancer. PET/CT and PET/MRI may determine which scanner is best for the patient's type of cancer and other types of cancers.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):


  • Drug: Ga-68-DOTA-TATE
  • Drug: F-18 FDG
  • Device: Positron Emission Tomography / Computed Tomography (PET/CT) Scan
  • Device: Positron Emission Tomography / Magnetic Resonance Imaging (PET/MRI) Scan


Phase 2


Inclusion Criteria:

   - Patient provides written informed consent

   - Patient is diagnosed with cancer

   - Patient is capable of complying with study procedures

   - Patient is able to remain still for duration of imaging procedure (approximately 90
   minutes total for PET/CT and PET/MRI)

Exclusion Criteria:

   - Patient is pregnant or nursing

   - Metallic implants (contraindicated for MRI)

   - Renal function impairment preventing administration of MRI contrast

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Not Recruiting